share_log

Clover Health | 10-Q: Q3 2024 Earnings Report

Clover Health | 10-Q: Q3 2024 Earnings Report

Clover Health | 10-Q：2024财年三季报
美股SEC公告 ·  2024/11/08 21:14

Moomoo AI 已提取核心信息

Clover Health reported strong Q3 2024 financial results with total revenue increasing 8.2% to $331 million, driven by a 7.1% rise in premiums earned to $322.6 million. The company significantly narrowed its net loss to $9.2 million from $41.5 million in Q3 2023, while maintaining a stable medical care ratio of 78.0%.The company demonstrated improved operational efficiency with a 9.2% reduction in salaries and benefits to $55.0 million and a 14.2% decrease in general and administrative expenses to $35.2 million. Other income grew 75.2% to $8.4 million, benefiting from higher interest rates. The Insurance segment served 81,110 Medicare Advantage members across five states.Notable developments include CMS increasing Clover's PPO Medicare Advantage plans rating to 4 Stars for 2025, which will enable a 5% quality bonus increase in benchmark rates for 2026. The company also launched Counterpart Health, a new SaaS solution to extend its AI-powered care management platform to external Medicare Advantage payors and providers.
Clover Health reported strong Q3 2024 financial results with total revenue increasing 8.2% to $331 million, driven by a 7.1% rise in premiums earned to $322.6 million. The company significantly narrowed its net loss to $9.2 million from $41.5 million in Q3 2023, while maintaining a stable medical care ratio of 78.0%.The company demonstrated improved operational efficiency with a 9.2% reduction in salaries and benefits to $55.0 million and a 14.2% decrease in general and administrative expenses to $35.2 million. Other income grew 75.2% to $8.4 million, benefiting from higher interest rates. The Insurance segment served 81,110 Medicare Advantage members across five states.Notable developments include CMS increasing Clover's PPO Medicare Advantage plans rating to 4 Stars for 2025, which will enable a 5% quality bonus increase in benchmark rates for 2026. The company also launched Counterpart Health, a new SaaS solution to extend its AI-powered care management platform to external Medicare Advantage payors and providers.
Clover Health在2024年第三季度报告了强劲的财务业绩，总营业收入增长了8.2%，达到了33100万，主要得益于保费收入增长了7.1%，达到了32260万。公司显著缩小了净亏损，从2023年第三季度的4150万降至920万，同时保持了稳定的医疗保健比率为78.0%。公司展现了提高的运营效率，薪资和福利下降了9.2%，降至5500万，管理费用下降了14.2%，降至3520万。其他收入增长了75.2%，达到了840万，受益于更高的利率期货。保险部门在五个州服务了81,110名医疗保险优先计划成员。值得注意的发展包括CMS将Clover的PPO医疗保险优先计划评级提高到2025年的4星，这将使得2026年的基准费率质量奖金增加5%。公司还推出了Counterpart Health，这是一种新的SaaS-云计算解决方案，旨在将其基于人工智能的护理管理平台扩展到外部医疗保险优先支付者和提供者。
Clover Health在2024年第三季度报告了强劲的财务业绩，总营业收入增长了8.2%，达到了33100万，主要得益于保费收入增长了7.1%，达到了32260万。公司显著缩小了净亏损，从2023年第三季度的4150万降至920万，同时保持了稳定的医疗保健比率为78.0%。公司展现了提高的运营效率，薪资和福利下降了9.2%，降至5500万，管理费用下降了14.2%，降至3520万。其他收入增长了75.2%，达到了840万，受益于更高的利率期货。保险部门在五个州服务了81,110名医疗保险优先计划成员。值得注意的发展包括CMS将Clover的PPO医疗保险优先计划评级提高到2025年的4星，这将使得2026年的基准费率质量奖金增加5%。公司还推出了Counterpart Health，这是一种新的SaaS-云计算解决方案，旨在将其基于人工智能的护理管理平台扩展到外部医疗保险优先支付者和提供者。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

独立文件3  查看翻译

独立文件4  查看翻译

独立文件5  查看翻译

独立文件6  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Alignment Healthcare
    ALHC
    -- 18.300
    信诺
    CI
    -- 325.040
    联合健康
    UNH
    -- 516.040
    Elevance Health
    ELV
    -- 432.000
    Molina Healthcare
    MOH
    -- 322.850
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    FOMC维持利率但不确定性高企：美股后市走向如何？
    🎙️讨论 1. 美联储强调政策路径存在“高度不确定性”，你更关注利率预期变化还是经济数据对市场的短期影响？ 2. 若核心通胀维持高位，哪类板块更具交易机会——防御型股票还是科技成长股？ 展开
    联邦公开市场委员会新闻发布会，2025年3月19日